Inhibiting macrophage PI3Kγ to enhance immunotherapy

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The role of PI3Kγ in metabolism and macrophage activation

The class 1 phosphoinositide 3-kinase (PI3K) is a family of enzymes which add a phosphate group in position 3 to the membrane lipid phosphatidylinositol4,5-bisphosphate to generate the second-messenger phosphatidylinositol-3,4,5-trisphosphate. The class-1 PI3K family is further subdivided into class-1A and class1B. Class-1A PI3Ks comprises PI3Kα; PI3Kβ; and PI3Kδ, which are typically recruited ...

متن کامل

Harnessing the Microbiome to Enhance Cancer Immunotherapy

The microbiota plays a key role in regulating the innate and adaptive immune system. Herein, we review the immunological aspects of the microbiota in tumor immunity in mice and man, with a focus on toll-like receptor (TLR) agonists, vaccines, checkpoint modulators, chemotherapy, and adoptive T cell transfer (ACT) therapies. We propose innovative treatments that may safely harness the microbiota...

متن کامل

More Paths to PI3Kγ

In the huge collection of molecules that underpin mammalian biology, only a small number stand out as targets for drug development. PI3Kc is one such molecule that has received substantial investments to assess whether inhibitors can be developed as potential therapeutics. Although many studies have addressed the structure and regulation of PI3Kc, our understanding of the enzyme is far from com...

متن کامل

Rewiring cancer cell death to enhance oncolytic viro-immunotherapy

Oncolytic viruses are novel immunotherapeutic agents that appear to mediate potent antineoplastic effects in both preclinical and clinical settings. Recent studies demonstrate that manipulating the mechanisms whereby cancer cells die in the course of oncolytic virotherapy has potential to boost anticancer immune responses.

متن کامل

Use of CD200 blockade inhibitor to enhance glioma immunotherapy

Background Utilizing tumors as a source of vaccine antigens in immunotherapy has demonstrated promising results. However, to date, researchers have failed to overcome the complex interplay between the tumor and its surrounding microenvironment resulting in T cell tolerance. The progression to a productive immune response involves a number of immunological checkpoints to be passed. Checkpoints s...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Cell Research

سال: 2016

ISSN: 1001-0602,1748-7838

DOI: 10.1038/cr.2016.132